• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013年中国的癌症发病率和死亡率

Cancer incidence and mortality in China, 2013.

作者信息

Chen Wanqing, Zheng Rongshou, Zhang Siwei, Zeng Hongmei, Xia Changfa, Zuo Tingting, Yang Zhixun, Zou Xiaonong, He Jie

机构信息

National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

出版信息

Cancer Lett. 2017 Aug 10;401:63-71. doi: 10.1016/j.canlet.2017.04.024. Epub 2017 May 3.

DOI:10.1016/j.canlet.2017.04.024
PMID:28476483
Abstract

OBJECTIVE

National Central Cancer Registry of China (NCCRC) updated nationwide statistics of cancer incidence and mortality in China using population-based cancer registration data in 2013 from all available cancer registries.

METHODS

In 2016, 255 registries' data were qualified and included in this analysis. We estimated numbers of new cancer cases and deaths in China in 2013 using age-specific rates and corresponding national population stratified by area, sex, age group (0, 1-4, 5-9, 10-14…85+) and cancer type. The world Segi's population was applied for age-standardized rates. All rates were expressed per 100,000 person-year.

RESULTS

A total of 3,682,000 new cancer cases and 2,229,300 cancer deaths were estimated in China in 2013. Cancers of lung, female breast, stomach, liver, colon-rectum and esophagus were the most common cancers, accounting for about half of all cancer new cases. Lung cancer, liver cancer, stomach cancer, esophageal cancer, colorectal cancer were the five leading causes of cancer death, accounting for about 60% of all cancer deaths. The cancer patterns showed differences not only between male and female, but also among different geographic regions in China. For overall cancers, the age-standardized incidence rates were stable during the past decades in male, but significantly increased by 2.2% per year in female.

CONCLUSIONS

Cancer poses a major threat to public health and the cancer burden keep raising in China. The annual updated cancer statistics can provide scientific basis for cancer prevention and control.

摘要

目的

中国国家癌症中心(NCCRC)利用2013年所有可用癌症登记处基于人群的癌症登记数据,更新了中国全国癌症发病率和死亡率的统计数据。

方法

2016年,255个登记处的数据符合要求并纳入本分析。我们使用特定年龄发病率以及按地区、性别、年龄组(0、1 - 4、5 - 9、10 - 14…85 +)和癌症类型分层的相应全国人口,估算了2013年中国新发癌症病例数和死亡数。采用世界标准人口计算年龄标准化率。所有发病率均以每10万人年表示。

结果

2013年中国估计共有368.2万例新发癌症病例和222.93万例癌症死亡病例。肺癌、女性乳腺癌、胃癌、肝癌、结直肠癌和食管癌是最常见的癌症,约占所有癌症新发病例的一半。肺癌、肝癌、胃癌、食管癌、结直肠癌是癌症死亡的五大主要原因,约占所有癌症死亡的60%。癌症模式不仅在男性和女性之间存在差异,在中国不同地理区域之间也存在差异。对于所有癌症而言,过去几十年男性年龄标准化发病率保持稳定,但女性每年显著上升2.2%。

结论

癌症对公众健康构成重大威胁,中国的癌症负担持续上升。年度更新的癌症统计数据可为癌症防控提供科学依据。

相似文献

1
Cancer incidence and mortality in China, 2013.2013年中国的癌症发病率和死亡率
Cancer Lett. 2017 Aug 10;401:63-71. doi: 10.1016/j.canlet.2017.04.024. Epub 2017 May 3.
2
[Report of cancer epidemiology in China, 2015].《2015年中国癌症流行病学报告》
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005.
3
[Incidence and mortality of cancers appeared in the Hebei provincial cancer registry system in 2011].2011年河北省癌症登记系统中出现的癌症发病率和死亡率
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Aug;36(8):846-51.
4
The incidence and mortality of major cancers in China, 2012.2012年中国主要癌症的发病率和死亡率。
Chin J Cancer. 2016 Aug 2;35(1):73. doi: 10.1186/s40880-016-0137-8.
5
[Analysis of cancer incidence and mortality in Henan province, 2009].[2009年河南省癌症发病率与死亡率分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Jul;47(7):597-602.
6
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
7
[Report of cancer incidence and mortality in Jiangsu Province in 2013].[2013年江苏省癌症发病与死亡报告]
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Aug 6;51(8):703-710. doi: 10.3760/cma.j.issn.0253-9624.2017.08.009.
8
[The incidence and mortality of lung cancer in China, 2014].[2014年中国肺癌的发病率和死亡率]
Zhonghua Zhong Liu Za Zhi. 2018 Nov 23;40(11):805-811. doi: 10.3760/cma.j.issn.0253-3766.2018.11.002.
9
[Report of Cancer Incidence and Mortality in China, 2014].《2014年中国癌症发病与死亡报告》
Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):5-13. doi: 10.3760/cma.j.issn.0253-3766.2018.01.002.
10
Cancer Incidence and Mortality Survey in Wuwei, Gansu Province, Northwestern China from 2003 to 2012: A Retrospective Population-based Study.2003年至2012年中国西北甘肃省武威市癌症发病率和死亡率调查:一项基于人群的回顾性研究
Chin Med J (Engl). 2016 Mar 20;129(6):636-44. doi: 10.4103/0366-6999.177969.

引用本文的文献

1
Preoperative contrast-enhanced ultrasound combined with intra-lymph node methylene blue injection for sentinel lymph node identification: a minimally invasive sentinel lymph node biopsy tracing approach.术前超声造影联合淋巴结内注射亚甲蓝用于前哨淋巴结识别:一种微创前哨淋巴结活检示踪方法。
Eur Radiol. 2025 Aug 21. doi: 10.1007/s00330-025-11932-3.
2
Trends in cancer incidence and mortality in the process of metropolitanization of Shanghai, 1973-2017.1973 - 2017年上海大都市化进程中的癌症发病率和死亡率趋势
Front Oncol. 2025 Aug 1;15:1615492. doi: 10.3389/fonc.2025.1615492. eCollection 2025.
3
Divergent trends in the burden of esophageal, gastric, and liver cancers in China.
中国食管癌、胃癌和肝癌负担的不同趋势。
J Natl Cancer Cent. 2025 May 29;5(3):306-312. doi: 10.1016/j.jncc.2025.05.001. eCollection 2025 Jun.
4
Optimizing breast cancer ultrasound diagnosis: a comparative study of AI model performance and image resolution.优化乳腺癌超声诊断:人工智能模型性能与图像分辨率的比较研究
Front Oncol. 2025 Jun 6;15:1536365. doi: 10.3389/fonc.2025.1536365. eCollection 2025.
5
Discovery of FLF-15 as a novel selective inhibitor of ADAM17 to prevent hepatocellular carcinoma metastasis.发现FLF-15作为一种新型的ADAM17选择性抑制剂可预防肝细胞癌转移。
Mol Divers. 2025 Jun 26. doi: 10.1007/s11030-025-11275-7.
6
Interaction between Maslinic acid and HSF1 enhances the ubiquitin degradation of HSF1, resulting in the inhibitory effect of pancreatic cancer.山楂酸与热休克因子1(HSF1)之间的相互作用增强了HSF1的泛素化降解,从而产生对胰腺癌的抑制作用。
Discov Oncol. 2025 Jun 12;16(1):1069. doi: 10.1007/s12672-025-02786-8.
7
The application of multi-arc volumetric modulated arc therapy and fixed-field intensity modulated radiotherapy in the treatment of gynecologic cancer with large planning target volume.多弧容积调强弧形放疗和固定野调强放疗在大计划靶区容积妇科肿瘤治疗中的应用
Phys Eng Sci Med. 2025 Apr 22. doi: 10.1007/s13246-025-01538-w.
8
LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress.LPCAT3通过介导铁死亡和内质网应激来调节ccRCC患者的免疫浸润和预后。
Discov Oncol. 2025 Apr 19;16(1):574. doi: 10.1007/s12672-025-02283-y.
9
Clinical significances of gene expression in circulating tumor cells of patients with breast cancer.乳腺癌患者循环肿瘤细胞中基因表达的临床意义。
Biomed Rep. 2025 Mar 11;22(5):82. doi: 10.3892/br.2025.1960. eCollection 2025 May.
10
Disability-adjusted life years for colorectal cancer in China, 2017-2030: A prevalence-based analysis focusing on the impact of screening coverage and the application of local weights.2017 - 2030年中国结直肠癌的伤残调整生命年:基于患病率的分析,重点关注筛查覆盖率的影响及局部权重的应用
Chin Med J (Engl). 2025 Apr 20;138(8):962-972. doi: 10.1097/CM9.0000000000003457. Epub 2025 Mar 27.